SCHEMBL14101557

SCHEMBL14101557

CC1(C)c2ccccc2-c2ccc(-c3ccc4sc5ccc(-c6c7ccccc7cc7ccccc67)cc5c4c3)cc21

nearest known ligand 0.38

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
PDK2 Q15119 8/20 0.32
NQO1 P15559 1/20 0.31
NQO2 P16083 1/20 0.31
CES1 P23141 1/20 0.31
ROCK1 Q13464 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101559 0.96 ALOX5 (0.34) ALOX5MGAMGAASIMGAM2
SCHEMBL17944396 0.89 ALK (0.31) PDK2
SCHEMBL21687079 0.89 GPR3 (0.37) ALOX5PDK2
SCHEMBL10018885 0.88 PDK2 (0.38) PDK2
SCHEMBL5552172 0.88 ALOX5 (0.46) ALOX5MGAMGAASIMGAM2
SCHEMBL13488104 0.88 GPR3 (0.34) ALOX5PDK2
SCHEMBL27867338 0.87 ALOX5 (0.41) ALOX5PDK2CES1
SCHEMBL18086207 0.87 GPR3 (0.40) ALOX5PDK2
SCHEMBL19110385 0.87 ALOX5 (0.36) ALOX5MGAMGAASIMGAM2
SCHEMBL13488031 0.87 S1PR5 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR ALOX5 1860/4885MGAM 3533/4885GAA 3062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.